U.S., April 2 -- ClinicalTrials.gov registry received information related to the study (NCT07504783) titled 'A Study to Evaluate the Real-world Experience and Satisfaction Associated With Ofatumumab' on March 26.
Brief Summary: The aim of this study is to assess physician and patient satisfaction with ofatumumab using data collected from physicians and their multiple sclerosis (MS) patients in real-world clinical practice across the United Kingdom (UK), France, Germany, Italy, Spain, China, Japan, and Brazil.
Study Start Date: Jan. 22
Study Type: OBSERVATIONAL
Condition:
Multiple Sclerosis
Recruitment Status: ACTIVE_NOT_RECRUITING
Sponsor: Novartis Pharmaceuticals
Disclaimer: Curated by HT Syndication....